60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTPW) Short Interest Update

60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTPW) was the recipient of a large decline in short interest in December. As of December 31st, there was short interest totaling 511 shares, a decline of 35.6% from the December 15th total of 793 shares. Based on an average daily volume of 5,628 shares, the short-interest ratio is presently 0.1 days. Based on an average daily volume of 5,628 shares, the short-interest ratio is presently 0.1 days.

60 Degrees Pharmaceuticals Stock Up 8.7%

Shares of NASDAQ:SXTPW traded up $0.00 during midday trading on Friday, reaching $0.06. The company’s stock had a trading volume of 4,970 shares, compared to its average volume of 2,081. The firm has a 50 day moving average of $0.05 and a 200-day moving average of $0.06. 60 Degrees Pharmaceuticals has a 12-month low of $0.02 and a 12-month high of $0.16.

About 60 Degrees Pharmaceuticals

60 Degrees Pharmaceuticals, Inc operates as a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19; Tafenoquine for fungal lung infections, tick-borne diseases, candidiasis, and other infectious and non-infectious diseases; and Celgosivir for respiratory viruses and dengue.